Investigating the Clinical Utility of Three Protocols of Hepatobiliary Iminodiacetic Acid Scans in Gallbladder Dyskinesia
Abstract
Purpose: Hepatobiliary iminodiacetic acid (HIDA) scans assess gallbladder function by measuring gallbladder ejection fraction (GBEF) to help diagnose biliary dyskinesia, a functional disorder causing biliary-type pain with no structural abnormalities on ultrasound. Various HIDA protocols use different stimulants and imaging times, but their comparative clinical utility and impact on patient outcomes remain unclear. This study aimed to compare GBEF values, surgical intervention rates, pathology, and symptom resolution across three common HIDA protocols.
Methods: A retrospective review of 525 patients with abdominal pain, normal biliary ultrasound, and abnormal HIDA scans (GBEF ≤40% or radiologist opinion) from 2018–2022 was performed. Protocol 1 used intravenous sincalide with imaging at 30 minutes; Protocols 2 and 3 used oral stimulants (Ensure® and fatty meal) with imaging at 60 minutes. Demographic and clinical variables were compared using ANOVA, Welch’s ANOVA, Chi-square, and Fisher’s exact tests.
Results: Protocol 1 included 318 patients (60.6%), Protocol 2 had 175 (33.3%), and Protocol 3 had 32 (6.1%). Protocol 1 showed significantly lower mean GBEF values (60.7% ± 30.6) compared to Protocol 2 (74.9% ± 19.0; p<0.001), with greater variability. Cholecystectomy rates were higher in Protocol 1 (21.4%) versus Protocol 2 (9.7%; p=0.004). Symptom resolution post-surgery was similar across groups (~86%; p=0.839), as was final pathology (p=0.485).
Conclusions: Despite protocol differences affecting GBEF values and surgery rates, patient outcomes were comparable. Protocol 1 remains the gold standard, but Protocols 2 and 3 could serve as reasonable alternatives; prospective studies with standardized imaging times are needed to validate these findings.
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work



